cladribine News
Most Popular cladribine Story
Novartis wins landmark approval for oral MS drug
Novartis has won the blockbuster competition to be first on the U.S. market with an oral MS drug that can slow down the disease and reduce the risk of relapses. The FDA has approved Gilenya, and Read more...
Latest Headlines
- November 29, 2010
- October 11, 2010
- September 24, 2010
- September 22, 2010
- July 28, 2010
- June 8, 2010
- April 9, 2010
- January 21, 2010
- September 11, 2009
- April 30, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
